To view a copy of this license, visit About this article Cite this article alk Baaran, N., Dotan, I
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine
discuss prior authorization, copay assistance programs, or alternative treatments if cost is a barrier
This chart shows clinical trial protocols, not a prescription
[PMID: 16179519] PubMed record related to this compound for laboratory literature review
Bad breath One other commonly reported unwanted effect by semaglutide users is bad breath (halitosis)